Tumor necrosis factor-alpha antagonism with etanercept improves endothelial progenitor cell counts in patients with psoriasis: etanercept, vascular function and endothelial progenitor cells in psoriasis.
Publication
, Journal Article
Hayek, SS; Neuman, R; Kavtaradze, N; Sher, S; Jones, D; Li, Q; Zhao, L; Chen, SC; Waller, E; Quyyumi, A
Published in: Int J Cardiol
March 1, 2015
Duke Scholars
Published In
Int J Cardiol
DOI
EISSN
1874-1754
Publication Date
March 1, 2015
Volume
182
Start / End Page
387 / 389
Location
Netherlands
Related Subject Headings
- Vasodilation
- Vascular Stiffness
- Tumor Necrosis Factor-alpha
- Treatment Outcome
- Psoriasis
- Middle Aged
- Male
- Immunosuppressive Agents
- Humans
- Female
Citation
APA
Chicago
ICMJE
MLA
NLM
Hayek, S. S., Neuman, R., Kavtaradze, N., Sher, S., Jones, D., Li, Q., … Quyyumi, A. (2015). Tumor necrosis factor-alpha antagonism with etanercept improves endothelial progenitor cell counts in patients with psoriasis: etanercept, vascular function and endothelial progenitor cells in psoriasis. Int J Cardiol, 182, 387–389. https://doi.org/10.1016/j.ijcard.2014.12.093
Hayek, Salim S., Robert Neuman, Nino Kavtaradze, Salman Sher, Dean Jones, Qunna Li, Liping Zhao, Suephy C. Chen, Edmund Waller, and Arshed Quyyumi. “Tumor necrosis factor-alpha antagonism with etanercept improves endothelial progenitor cell counts in patients with psoriasis: etanercept, vascular function and endothelial progenitor cells in psoriasis.” Int J Cardiol 182 (March 1, 2015): 387–89. https://doi.org/10.1016/j.ijcard.2014.12.093.
Hayek SS, Neuman R, Kavtaradze N, Sher S, Jones D, Li Q, et al. Tumor necrosis factor-alpha antagonism with etanercept improves endothelial progenitor cell counts in patients with psoriasis: etanercept, vascular function and endothelial progenitor cells in psoriasis. Int J Cardiol. 2015 Mar 1;182:387–9.
Hayek, Salim S., et al. “Tumor necrosis factor-alpha antagonism with etanercept improves endothelial progenitor cell counts in patients with psoriasis: etanercept, vascular function and endothelial progenitor cells in psoriasis.” Int J Cardiol, vol. 182, Mar. 2015, pp. 387–89. Pubmed, doi:10.1016/j.ijcard.2014.12.093.
Hayek SS, Neuman R, Kavtaradze N, Sher S, Jones D, Li Q, Zhao L, Chen SC, Waller E, Quyyumi A. Tumor necrosis factor-alpha antagonism with etanercept improves endothelial progenitor cell counts in patients with psoriasis: etanercept, vascular function and endothelial progenitor cells in psoriasis. Int J Cardiol. 2015 Mar 1;182:387–389.
Published In
Int J Cardiol
DOI
EISSN
1874-1754
Publication Date
March 1, 2015
Volume
182
Start / End Page
387 / 389
Location
Netherlands
Related Subject Headings
- Vasodilation
- Vascular Stiffness
- Tumor Necrosis Factor-alpha
- Treatment Outcome
- Psoriasis
- Middle Aged
- Male
- Immunosuppressive Agents
- Humans
- Female